Fresenius Medical Care Ventures
Overview
Provider of dialysis products and services for chronic kidney failure.
Founded
1912
Deals · 12mo
0
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
EGenesis | Sep 2024Participated | $191 MSeries D | |
Memo Therapeutics | May 2024Participated | $22 MSeries C | |
Memo Therapeutics | Nov 2023Participated | $28 MSeries C | |
Retia Medical | Jul 2022Led | $15 MSeries B | |
Memo Therapeutics | Feb 2022Participated | $40 MSeries B | |
EGenesis | Mar 2021Participated | $125 MSeries C | |
EGenesis | Nov 2019Led | $100 MSeries B | |
Modulim | Jan 2019Participated | $7 MSeries B | |
Tridiuum | Dec 2018Participated | $10 MSeries B | |
Corvidia | Apr 2018Participated | $60 MSeries B | |
Modulim | Nov 2017Participated | $4 MSeries A | |
ExThera Medical | Jun 2016Led | $15 MSeries B | |
EGenesis | Sep 2024Participated | $191 MSeries D | |
Memo Therapeutics | May 2024Participated | $22 MSeries C | |
Memo Therapeutics | Nov 2023Participated | $28 MSeries C | |
Retia Medical | Jul 2022Led | $15 MSeries B | |
Memo Therapeutics | Feb 2022Participated | $40 MSeries B | |
EGenesis | Mar 2021Participated | $125 MSeries C | |
EGenesis | Nov 2019Led | $100 MSeries B | |
Modulim | Jan 2019Participated | $7 MSeries B | |
Tridiuum | Dec 2018Participated | $10 MSeries B | |
Corvidia | Apr 2018Participated | $60 MSeries B | |
Modulim | Nov 2017Participated | $4 MSeries A | |
ExThera Medical | Jun 2016Led | $15 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 1 |
| Series B | 3 | 4 |
| Series C+ | 0 | 4 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '16 | 1 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 1 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 1 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 1 |
| Jan '19 | 1 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 1 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 1 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 10 |
| Networks, Cloud & Communication | 3 |
| Consumer & Lifestyle | 2 |
| Marketing & Advertising | 2 |
| Hardware & Robotics | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 2 |
| $10M-$25M | 3 |
| $25M-$50M | 2 |
| $50M-$100M | 1 |
| $100M-$250M | 3 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 9 |
| Europe | 3 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Adjuvant Capital | 3 |
| Alta Partners | 3 |
| ARCH Venture Partners | 3 |
| GF Group | 3 |
| Khosla Ventures | 3 |
| Leaps by Bayer | 3 |
| Swisscanto Invest | 3 |
| Verve Ventures | 3 |
| Vesalius Biocapital | 3 |
| Farallon Capital Management | 2 |
| Grey Sky Venture Partners | 2 |
| HBM Healthcare Investments | 2 |
| Mitsubishi UFJ Capital | 2 |
| Pureos Bioventures | 2 |
| Redalpine | 2 |
| Schroders Capital | 2 |
| Wellington Partners | 2 |
| Altium Capital | 1 |
| Andera Partners | 1 |
| Apple Tree Partners | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 25% |
| Participating | 9 | 75% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 3 | 100% |
| Co-led | 0 | 0% |
Team
National Nursing Coordinator
Executive Chairman of the Board
Senior Vice President, Operations President, East Division
Vice President
President
Group Vice President
Vice President Marketing Hospital
Chairman of the Management Board